QIAGEN

It was a pleasure for our QIAGEN Manchester team to host for a visit Sir Patrick Vallance, the Minister for the Department for Science, Innovation and Technology of the United Kingdom.   During the visit, Sir Patrick toured the facility and met with our team, who provided an overview of our latest innovations and strategic initiatives – all aligned with advancing #science and improving #healthcare.   He took a deep interest in the products, especially our QIAcuity digital PCR platform and the expanding range of applications, as well as the role of companion diagnostics and their potential to make a difference in improving outcomes for patients with cancer as well as chronic and hereditary diseases.   This visit of such a high-ranking UK government official was a great opportunity to show how QIAGEN is achieving our vision of making improvements in life possible.

🤔 If you have ever asked yourself how to be more sustainable in the lab, then we have an answer for you: Reduce, Reuse, and Recycle!   ✅ Watch this video and join Nathan Susnik, PhD, one of our senior content managers, as he shows you how, with one tiny snap of the fingers, you can change so much!

The human body has trillions of microbes aiding digestion, boosting immunity, and influencing metabolism. So why not the same for plants and soil? Learn how manipulating plant microbiomes can help crop security 👉 https://lnkd.in/efbZTcBf

🎉 We are excited to share that QIAGEN LLC has been recognized as a Best Place to Work for Disability Inclusion by the Disability Equality Index, receiving a top score! ✅ The Disability Equality Index is widely acknowledged as the most comprehensive assessment tool that helps companies build a roadmap of measurable and tangible actions toward disability inclusion and equality. The Index measures a range of criteria for disability inclusion, all of which are reflected at QIAGEN LLC and throughout our global QIAGEN organization. 🤝 Many thanks to all QIAGENers, who continuously work to create an inclusive and welcoming environment for all employees, ensuring everyone has an equal opportunity to thrive and make a difference!

Whole genome sequencing of tuberculosis with no cell culture. Learn more 👉 https://lnkd.in/edtezyx7   Yes, it’s true, so we’ll say it again. The new QIAseq xHYB Mycobacterium tuberculosis Panel is designed using the seven major lineages of MTB and provides coverage of all AMR markers with no cell culture. 

We are thrilled to partner with the Snow Molecular Anthropology Lab at the University of Montana to enhance the identification of human remains of Indigenous people and African Americans. Learn more 👉 https://lnkd.in/gFeFXxjw   ✅ Our partnership drives the implementation of next-generation sequencing and forensic investigative genetic genealogy in identifying human remains.   ✅ We provide instruments, kits and training for building the first Inidgenous-owned DNA database for the Blackfeet Nation and identifying human remains of African Americans who were part of the convict leasing system.   ✅ This collaboration underlines our leading position in forensic applications and human identification, exemplifying our commitment to advancing forensic science and providing answers to victims and their families.

 🌟 Gastrointestinal (GI) panels are transforming care for patients with suspected GI infections. They’re reducing diagnosis times, cutting down on invasive tests and ensuring peace of mind. 🔍 Curious about how they can support your practice? ✅ Learn more about these advancements through clinical cases and publication summaries at 👉 https://lnkd.in/evfh8SWu #Healthcare #GIPanels #PatientCare #ClinicalCases

In this week’s interview with BiotechTV, our CEO Thierry BERNARD describes latest sample, assay, and bioinformatics technologies that are powering life sciences and molecular diagnostics. He discusses the scientific and clinical advances underlying our focus areas: sample technologies, QuantiFERON, QIAstat-Dx, and digital PCR (dPCR). Watch the full interview to learn how these innovations are powering the future of research and healthcare 👉 https://lnkd.in/gAKWgWuq

Up to 13 million people in the US carry latent TB infection – and children are at increased risk for progression from infection to contagious active TB disease. Children are also commonly exposed to settings with a higher risk for TB transmission, like schools and childcare centers. 

At QIAGEN, we believe that our commitment to diversity and inclusion drives our success and innovation. By creating an environment where everyone feels accepted and valued, we empower our team to reach their highest potential.    #pridemonth #LGBTQ #QIAversity #diversity #inclusion